Stoke Therapeutics Inc (NAS:STOK)
$ 13.05 -0.05 (-0.38%) Market Cap: 690.88 Mil Enterprise Value: 409.98 Mil PE Ratio: 0 PB Ratio: 2.81 GF Score: 40/100

Stoke Therapeutics Inc at Cowen Health Care Conference (Virtual) Transcript

Mar 07, 2022 / 02:10PM GMT
Release Date Price: $19.71 (+2.92%)
Yaron Werber
Cowen and Company, LLC - Analyst

Okay. Well, good morning, everybody, and thank you once again for joining us for the 42nd Annual Health Care Conference at Cowen. I'm Yaron Werber from the biotech team. And it's a great pleasure to moderate the Orphan Neurology Panel with my colleagues, Brendan Smith and Eva Privitera.

We really have a terrific session today. We have with us, Shoshana Shendelman, who is the Founder and CEO of Applied Therapeutics; Brett Monia, who's the CEO of Ionis; Jeremy Levin, who's the CEO of Ovid; and Ed Kaye from Stoke. Gentlemen and lady, thank you so much for joining us. Great to see you.

Brett Monia
Ionis Pharmaceuticals, Inc - CEO

Thank you.

Ed Kaye
Stoke Therapeutics, Inc. - CEO & Director

Thank you very much.

Questions & Answers

Yaron Werber
Cowen and Company, LLC - Analyst

So we have a lot to talk about. There's a lot going on in orphan neuro these days and you're all essentially developing therapies

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot